Kellerhals Carrard advised BVF on the deal while Sheppard Mullin served as counsel to Laidlaw & Company (UK) Ltd. NLS Pharmaceutics Ltd. (NASDAQ: NLSP), a Swiss...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here